Background and Aim: To compare the efficacy and safety of esophagogastroduodenoscopy (EGD)-colonoscopy and colonoscopy-EGD sequences for patients subjected to same-day bidirectional endoscopy under remifentanil and propofol sedation.
INTRODUCTION
E NDOSCOPY, INCLUDING ESOPHAGOGASTRO-DUODENOSCOPY (EGD) and colonoscopy, is currently the standard method for evaluating gastrointestinal (GI) symptoms and assessing gastrointestinal mucosa. 1, 2 Benefits of same-day bidirectional endoscopy (BDE) include shorter hospital stay, reduced medical costs, and quicker health-care decision-making. 3 Moreover, this procedure has now been carried out in more than 10% of patients undergoing endoscopy in the USA. 1 BDE is especially beneficial for evaluation of various clinical situations, such as active GI bleeding, iron-deficiency anemia, positive fecal occult blood tests, abdominal pain, and cancer screening. 2, [4] [5] [6] However, the optimal sequence of the two procedures (EGD-colonoscopy versus colonoscopy-EGD) conducted during same-day bidirectional endoscopy has not yet been established. In 2010, Cho et al. investigated this question in procedures carried out without sedation, and showed that EGD-colonoscopy is superior to colonoscopy-EGD and that the colonoscopy-EGD sequence is more stressful to patients. 7 In 2011, Hsieh et al. also suggested that EGDcolonoscopy is the optimal sequence for same-day bidirectional endoscopy carried out under moderate sedation as this procedure sequence was better tolerated and patients required a lower dose of propofol. 8 In contrast, in 2013, Choi et al. found that the procedural sequence did not affect colonoscopy performance quality and that patients in the EGD-colonoscopy group experienced less subjective discomfort during EGD. 9 A study by Carter et al. in 2014 showed no significant difference in the discomfort and satisfaction of patients during BDE, regardless of the procedural sequence. 10 Thus, the results from these different studies are conflicting, and the sample sizes of these studies were relatively small. Additionally, there is a lack of data on the effects of routine sedation and endoscopic procedures on cardiorespiratory parameters of patients subjected to BDE.
The present study aimed to compare the efficacy and safety of the two procedural sequences to determine the superior procedural sequence for patients undergoing BDE under remifentanil and propofol sedation. ChiCTR-IOR-16007946). Primary endpoint of the study was the total dose of propofol required for carrying out BDE under sedation. The sample size was calculated from the results of our pilot study. Power calculations estimated that 101 patients in each arm would ensure 80% power of detecting at least a 2.1 mL difference in the dose of propofol, given a standard deviation of 5.3 mL (5% significance level, two-sided test). Therefore, 101 patients per group were required (where a = 0.05 [two-tailed], b = 0.2).
METHODS
After referral from general practitioners or gastroenterologists for GI symptoms, consecutive patients of either sex (n = 289) presenting to our outpatient gastroenterology clinics were scheduled for same-day bidirectional endoscopy between 16 February 2016 and 30 April 2016.
Inclusion criteria included: age between 18 and 70 years; able to respond to self-administered questionnaires; and ASA (American Society of Anesthesiologists) class I to III, enabling performance of same-day bidirectional endoscopy.
Exclusion criteria included: allergies to emulsions or opioids; uncontrolled diabetes mellitus, serious hepatic, or renal dysfunction, and cardiopulmonary compromise or previous history of gastric and/or colorectal surgery; uncontrolled hypertension, systolic/diastolic blood pressure >180/90 mmHg; second-degree atrioventricular block or complete left bundle branch block; pregnancy or lactation; obstructive lesions of the gastrointestinal tract; psychiatric conditions and thus inability to provide informed consent; and refusal to provide an informed consent.
After initial screening and receipt of written informed consent, a total of 209 eligible patients were randomly assigned to the EGD-colonoscopy (n = 106) or colonoscopy-EGD (n = 103) sequence groups based on a computer-generated list (Fig. 1) . Each patient received appropriate written pre-procedural instructions and their data were collected including age, height, weight, concomitant disease(s), and past medical and surgical history. All patients thoroughly followed the pre-procedural instructions.
Endoscopy
All patients had electrocardiography, routine blood tests, coagulation tests, overnight fasting, and a bowel cleansing before the bidirectional endoscopy. Patients were requested to drink 4 L polyethylene glycol electrolyte lavage (PEG-EL) solution (Shenzhen Wanhe Pharmaceutical Co., Ltd, Shenzhen, China) at least 4 h prior to receiving their bidirectional endoscopy. Nursing care (including counseling and abdominal massage) helped in obtaining patient cooperation and compliance.
Patients were placed in the left lateral decubitus position throughout the procedure and were continuously monitored by an assistant colonoscopist or colonoscopy nurse using an electronic multifunctional patient monitor unit (Mindray Medical, Shenzhen, China). Mean arterial pressure (MAP), pulse rate (PR), and oxygen saturation based on pulse oximetry (SpO 2 ) were monitored.
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Patients were infused with normal saline (0.9% NaCl) and nasal oxygen was given at a flow rate of 2 L/min. An independent anesthesiologist administered 30 mL of 0.5% oral dimethicone powder (Honghe Pharmaceutical Co., Ltd, Zigong, China) 30 min before gastroscopy, and 10 mL viscous oral lidocaine hydrochloride (Kangye Pharmaceutical Co., Ltd, Handan, China) 15 min before gastroscopy for oropharyngeal topical anesthesia. Patients were given standard premedications: 1 lg/kg remifentanil (Renfu Pharmaceutical Co., Yichang, China), and 2 mg/kg propofol (AstraZeneca Italy, Caponago, Italy). As per the requirement, additional doses of propofol (0.5 mg/kg) were given during EGD or colonoscopy for escalating the sedation, and patients were maintained at a Ramsay Sedation Scale (RSS) 12 >4 throughout the bidirectional endoscopy procedure.
Board-certified endoscopists (who had at least 5 years of experience and had carried out more than 500 EGD and Digestive Endoscopy 2017; 29: 330-337
Sequence of EGD and colonoscopy 331 colonoscopies each year) conducted EGD and colonoscopic examinations in all patients using an Olympus adult video upper gastrointestinal endoscope (GIF 260; Olympus Co. Ltd, Tokyo, Japan) and Olympus adult video colonoscope (CF 260). Once the first endoscopy was finished, the subsequent endoscopy was carried out immediately in both groups.
Patients were monitored in the recovery unit after the examination and were not discharged until they had regained consciousness. All patients were advised to eat only cold soft food for at least 2 h after the procedure. Patients were also advised to avoid driving as well as signing of legal documents during the first 24 h after the examination.
Data collection
Each patient's demographic data including age, sex, body mass index (BMI), ASA class, history of abdominal surgery, history of endoscopy, and indication for endoscopy were obtained before sedation.
During the procedure, MAP, HR, and SpO 2 were recorded at four time periods: before anesthesia; when the endoscope was guided into the gastric body; when the cecum was reached with the scope; and after the endoscopy procedure but before complete recovery. Procedure times for EGD and colonoscopy, cecal intubation time (when the colonoscope arrives at the ileocecal junction after insertion), and all adverse events (hypoxemia, hypotension, arrhythmia, vomiting, and other side-effects) were also recorded.
After the patients had fully recovered, propofol and remifentanil dosages; duration of procedure; recovery time; satisfaction levels of physician, anesthetist, and patient; and adverse events after recovery (e.g. nausea, vomiting, abdominal distension, cramps, and others) were recorded. Satisfaction levels of the physician, anesthetist, and patient were evaluated using a 10-point scale (poor, 1-4; fair, 5-7; good, [8] [9] [10] . 
Statistical analyses
Quantitative data with normal distribution were expressed as mean AE standard deviation (SD) and compared using independent t-tests or one-way or repeated-measures analysis of variance (ANOVA). All qualitative data are expressed as n (%) and compared using chi-squared tests or Fisher's exact tests. All P-values were two-tailed and P values <0.05 were considered statistically significant. All statistical calculations were done using Statistical Package for Social Sciences (SPSS) version 12.0 for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline characteristics of the patients O NE HUNDRED AND thirty-five males and 74 females with a mean age of 46.67 AE 11.56 years were included in the present study. The most common indication to carry out BDE was screening (46.89%). As shown in Table 1 , patients in the two groups were comparable in terms of their demographic and clinical data (P > 0.05). Cecal intubation rate was 100% in both groups.
Procedural characteristics and outcomes
As shown in Table 2 , a significantly higher dose of propofol was required during the entire examination (EGD and colonoscopy) in the colonoscopy-EGD sequence group (P = 0.023). There was no significant difference in the total duration of the endoscopies between the groups, but the patients in EGD-colonoscopy sequence group had significantly shorter recovery times (P < 0.001). There was no statistical significance in satisfaction of physicians, anesthetists, and patients between the groups.
Adverse effects were infrequent in the present study with no significant difference between the groups. Hypoxemia occurred in two patients in the EGD-colonoscopy sequence group, whereas the colonoscopy-EGD sequence group had one patient with propofol-induced changes of heart rate and rhythm, two patients with cough, and one patient with nausea/vomiting. There were no significant differences in pathological findings of EGD and colonoscopy, respectively, between the groups, including the diagnoses of benign or malignant diseases (Table 2 ).
Cardiopulmonary responses of patients
As shown in Figure 2 , there was no significant difference between the two groups in terms of heart rate, SpO 2 , and MAP before endoscopy. Heart rate, MAP, and SpO 2 significantly decreased during the endoscopy in the EGDcolonoscopy sequence group (P < 0.05), whereas heart rate and MAP significantly decreased during the endoscopy in the colonoscopy-EGD sequence group (P < 0.05). After the endoscopy, heart rate, MAP, and SpO 2 values significantly increased compared with these values during Figure 2 Cardiopulmonary responses. (a) Heart rate, (b) peripheral oxygen saturation, and (c) mean arterial pressure in patients with same-day bidirectional endoscopy. ■, esophagogastroduodenoscopy (EGD)-colonoscopy sequence group; □, colonoscopy-EGD sequence group. 1, Before the endoscopy procedure but after anesthesia; 2, at progression of the endoscope to the gastric body; 3, when the cecum could be reached with the scope; 4, after the endoscopy procedure but before recovery. *P < 0.05, **P < 0.01.
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Sequence of EGD and colonoscopy 335 the endoscopy in both groups (P < 0.05). However, apart from the heart rate, these values were significantly lower compared to the baseline values. Moreover, MAP in the EGD-colonoscopy sequence group was significantly higher than in the colonoscopy-EGD sequence group when the cecum was reached with the scope and during the recovery period (P < 0.05), whereas SpO 2 in the EGD-colonoscopy sequence group was lower than in the colonoscopy-EGD sequence group when the endoscope reached the gastric body (P < 0.05).
DISCUSSION

G
REAT ADVANCES IN endoscopic technology have enabled same-day BDE to be increasingly used for evaluation of GI symptoms and assessment of GI mucosa. 1, 2 The purpose of painless BDE is to improve patient adherence and help identify possible diseases (especially early-stage malignancies) as soon as possible. However, necessary preparations for visualization and gas insufflation during the first procedure can significantly affect the examination of the second procedure. 9 Moreover, anesthesia and endoscopic procedures may significantly alter cardiopulmonary responses. [13] [14] [15] Thus, this single-center, prospective, randomized study was designed to compare the efficacy and safety between these two procedural sequences for patients undergoing BDE.
During endoscopy, declining cardiorespiratory parameter data values among patients were similar to those reported by previous studies. 11, 15 After the endoscopy, heart rate, MAP, and SpO 2 values significantly increased compared with these values during the endoscopy in both groups (P < 0.05). This reflects the impact of routine sedation and endoscopic procedures on cardiorespiratory parameters of patients undergoing BDE. Moreover, MAP in the EGDcolonoscopy sequence group was significantly higher than in the colonoscopy-EGD sequence group when the cecum was intubated, as well as after the endoscopy procedure but before recovery (P < 0.05), thus indicating that the EGDcolonoscopy sequence has a lower influence on MAP.
Although SpO 2 in the EGD-colonoscopy sequence group was lower than in the colonoscopy-EGD sequence group during gastroscopy (P < 0.05), SpO 2 in both groups was <95% and there were no significant differences in SpO 2 during other time periods, especially after the procedure. Hence, this observation is unlikely to have any adverse impact on the patients.
As shown in Table 2 , the dosage of remifentanil used for standard premedication was similar between the groups. However, significantly higher doses of propofol were required during the entire examination (EGD and colonoscopy) in the colonoscopy-EGD sequence group compared to the EGD-colonoscopy sequence group (P = 0.023); a finding that also corresponds to the results of the study by Hsieh et al. 8 A study by Tang et al. also reported how significantly lower total doses of fentanyl and midazolam were required in the EGD-colonoscopy group. 16 The half-life of propofol in the brain is reportedly much longer than that in plasma. 17 Patients were still under the influence of propofol given for the first procedure; therefore, less propofol was required for the second procedure. However, as colonoscopy is usually more painful than EGD, the colonoscopy-EGD sequence group required higher doses of propofol. 18 Hence, the colonoscopy-EGD sequence group had a significantly longer mean recovery time than the EGDcolonoscopy sequence group. Therefore, it is beneficial to carry out the colonoscopy after EGD for patients undergoing BDE. Additionally, Cho et al. reported that the quality of EGD as assessed by various steps such as retroflexion and visualization of the angular fold were superior in the EGDcolonoscopy group compared to the colonoscopy-EGD sequence. 7 They also found that patients experienced greater subjective discomfort during EGD when in the colonoscopy-EGD group. 7 Hsieh et al. found that colonoscopy is better tolerated when EGD is carried out first. 8 Similar to the findings of previous reports, the duration and rate of detection of pathological findings did not differ significantly between the groups. 10 Furthermore, we also found that satisfaction of the endoscopist, anesthetist, and patient did not differ significantly between both groups.
There are several limitations in the present study. First, the endoscopist, anesthetist, and patient could not be blinded to the sequence of endoscopic performance in this study. Second, adverse effects were only collected during the procedure and immediately after the procedure; a longer timeframe recording adverse events should be considered.
In conclusion, the EGD-colonoscopy sequence may be considered the superior procedural sequence for same-day bidirectional endoscopy as a lower dose of propofol is required and recovery is faster with lesser influence on MAP during the procedure.
